Skandinaviska Enskilda Banken (SEB)
SGNT

Skandinaviska Enskilda Banken (SEB)’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-332,000
Closed -$4.97M – 744
2016
Q2 		$4.97M Buy
332,000
+18,500
+6% +$238K 0.06% 250
2016
Q1 		$3.81M Sell
313,500
-85,400
-21% -$1.2M 0.04% 294
2015
Q4 		$6.32M Buy
+398,900
New +$6.28M 0.08% 189

Skandinaviska Enskilda Banken (SEB)'s SGNT Position: Q3 2016 in Review

Skandinaviska Enskilda Banken (SEB) sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 332,000 shares — an estimated $4.97M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SGNT in Q4 2015 and held it in 3 quarters. The position peaked at $6.32M in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 332,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $4.97M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $6.32M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2016, filed 10 Nov 2016.